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Abstract
Background. Cigarette smoking has recently been recognized as a risk factor for developing
nodular glomerulosclerosis and has also been frequently encountered in patients with anti-glom-
erular basement membrane (anti-GBM) disease. However, the concurrent presence of both pat-
terns of glomerular injury has not been previously reported.
Material and methods. In this article, we describe three patients with non-diabetic nodular glo-
merulosclerosis, anti-GBM-like glomerulonephritis (GN) and a historyof heavysmoking.
Results. Our cohort included three patients, of which two were men (53 and 77 years old) and one
a 28-year-old woman. None of the patients had a history of diabetes mellitus but all of them were
heavy smokers who presented with renal insufﬁciency and proteinuria. Nodular glomerulosclerosis
and occasional small, non-circumferential crescents in different stages of development were
found on kidney biopsy. Immunoﬂuorescence microscopy studies showed intense linear IgG stain-
ing along the glomerular basement membranes in the absence of granular immune-type deposits.
Electron microscopy evaluation revealed prominent endothelial cell injury without detectable elec-
tron-dense deposits. One patient was dialysis-dependent a few months post-biopsy while the
other two patients maintained their kidney function 18 and 24 months post-biopsy but without a
signiﬁcant improvement of serum creatinine.
Conclusions. The combination of nodular glomerulosclerosis and anti-GBM-like GN appears to be a
distinct pattern of injury observed in a small subset of heavy smokers. Although this pattern of
glomerular injury might be less aggressive than the typical anti-GBM GN, it does not appear to
carry a favorable prognosis.
Keywords: anti-glomerular basement membrane glomerulonephritis; endothelial cell injury; nodular glomerulosclerosis;
smoking
Introduction
Cigarette smoking has been recognized as a risk factor for
development and progression of kidney damage [1, 2].
A study by Markowitz et al. [3] has shown that the vast
majority of patients with ‘idiopathic nodular glomerulo-
sclerosis’ (ING) were smokers. This association was soon
conﬁrmed by others [4–6]. Several studies have also
proposed a link between cigarette smoking and anti-
glomerular basement membrane (anti-GBM) disease. This
concept was based on the fact that a high proportion of
patients with Goodpasture syndrome were active smokers
[7–9]. Despite the aforementioned independent associ-
ation of smoking with nodular glomerulosclerosis and
anti-GBM disease, no studies have previously documented
the concurrent detection of both glomerular lesions in
smoker patients. Here, we present the ﬁrst report of three
patients with non-diabetic nodular glomerulosclerosis
and anti-GBM-like glomerulonephritis (GN) on a kidney
biopsy.
Material and methods
The study was performed under the approval of the Brig-
ham’s and Women’s Institutional Review Board (IRB#
2011P002692). Using our electronic reporting system, we
found a combination of nodular glomerulosclerosis and
features of anti-GBM-GN in three patients with kidney
biopsies during past 7 years (3 of 7675 kidney biopsies;
0.03% of all kidney biopsies).
All three biopsies were performed at outside institu-
tions. Kidney tissues from patients 2 and 3 were submitted
to the Brigham and Women’s Hospital (Boston, MA, USA)
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patient 1 was processed at the outside institution and the
light microscopy slides, immunoﬂuorescence microscopy
images, and electron microscopy grids were submitted to
our institution forconsultation.
Standard processing of renal biopsies for light, immuno-
ﬂuorescence and electron microscopy was performed for
each sample. For light microscopy evaluation, sections
were stained with hematoxylin and eosin (H&E), periodic
acid-Schiff (PAS), Jones’ methenamine silver, and trichrome
stains. For immunoﬂuorescence microscopy assessment,
the frozen sections were stained with antibodies speciﬁc
for the heavy chains of IgG, IgM, and IgA, C3 and C1q
complement components, kappa and lambda light chains,
ﬁbrin, and albumin. IgG subtyping with antibodies speciﬁc
for heavy chains of IgG1, IgG2, IgG3 and IgG4 was also
performed by the immunoﬂuorescence technique for all
three biopsies; for specimens from patients 1 and 2, IgG
subtyping was performed and interpreted at the Mayo
Clinic Laboratories (Rochester MN). For patient 3, IgG sub-
typing was performed and interpreted at the Brigham and
Women’sH o s p i t a l .
Results
Clinical and demographic features
This small cohort of patients included two men (53 and 77
years old) and one 28-year-old woman (Table 1). Two pa-
tients were Caucasian and one patient was Hispanic. None
of the patients had a clinical diagnosis of diabetes mellitus
but all of them were heavy smokers with a mean cumula-
tive intake of 42 pack/year. Patient 3 with the lowest
smoking cumulative intake (14 pack/year) is a 28 year-old
female who has been an active heavy smoker for the last
8 years prior to this presentation with intermittent use of
amphetamine. Noteworthy, none of the patients had a
long history of hypertension but all of them developed a
relatively recent increase in blood pressure (up to 3
months prior to biopsy). The patients did not present with
a signiﬁcant respiratory involvement such as pulmonary
hemorrhage and only one patient had an isolated episode
of mild hemoptysis. The three patients had mild lower ex-
tremity edema, microscopic or gross hematuria, and ele-
vated serum creatinine values [mean 301 µmol/L (3.4 mg/
dL)]. Protein was always detected in the urine and the
amount of proteinuria ranged between 1 and 6.4 g/24 h.
Laboratories revealed undetectable anti-neutrophilic cyto-
plasmic antibodies (ANCA), normal serum complement
levels and non-reactive hepatitis B and C panels in all
three patients. When performed, serum protein electro-
phoreses were negative (Table 1). ANA was negative in
two patients while it was detectable in low titer in one
patient (patient 2), who had negative anti-double-
stranded DNA (ds-DNA) antibodies (Table 1). Urine culture
was performed in one patient and was negative. Anti-GBM
antibodies were always negative byserum ELISA and posi-
tive in 1 of 2 patients by Western blot (Table 1).
Histology
Tissue sampling for light microscopy included a mean of
28 glomeruli (range: 21–42 glomeruli). Globally sclerosed
glomeruli were detected in all three samples (mean: 28%
of total glomeruli) (Table 2). All renal biopsies revealed
diffuse mesangial matrix expansion with nodule forma-
tion (Figure 1A–D) and foci of mesangiolysis (Figure 1A
and B). The glomerularcapillaries showed endothelial injury
with occasional microaneurysmal dilatation (Figure 1A).
The glomerular basement membranes also showed mild
Table 1. Demographic and clinical features
Patient 1 Patient 2 Patient 3
Age (years) 53 77 28
Sex Male Male Female
Race Caucasian Hispanic Caucasian
Past medical history
Diabetes mellitus No No No
Hypertension Recent onset (last 2 months) Recent onset (last 3 months) Recent onset (last month)
Smoking
(mean cumulative intake: pack/year)
Yes (53) Yes (59) Yes (14)
Signs and symptoms
Respiratory No
a One episode of mild hemoptysis No
Edema Mild lowerextremity Mild lower extremity Mild lower extremity
Hematuria Yes (microscopic) Yes (gross) Yes (microscopic)
Labs
Serum creatinine at biopsy µmol/L
(mg/dL)
283 (3.2) 398 (4.5) 230 (2.6)
Proteinuria Yes Yes Yes
Quantitative proteinuria (grams/24 h) 2.8 1 6.4
Serum albumin (g/dL) 3.6 3.6 3.1
Serum complement (C3, C4) WNR WNR WNR
Serum paraprotein (SPEPand/or
immunoﬁxation)
Negative Not performed Negative
Serum cryoglobulin Not performed Negative Not performed
Hepatitis panel (HBVand HCV) Negative Negative Negative
Anti-GBM antibodies ELISA: negative western blot: not
performed
ELISA: negative western blot:
positive
ELISA: negative western blot:
negative
ANA Negative Weak (1: 40) ; speckled Negative
ANCA Negative Negative Negative
Anti-dsDNA Not performed Negative Not performed
Urine culture Not performed Not performed Negative
WNR, within normal range; GBM, glomerular basement membranes; ELISA, enzyme-linked immunoabsorbent assay; ANCA, anti-neutrophilic cytoplasmic
antibodies; HBV, hepatitis B virus; HCV, hepatitis Cvirus; dsDNA, double-stranded DNA.
aAn old X-ray revealed nodular appearance; at that time a bronchial biopsy was suboptimal and non-diagnostic.
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sional small cellular crescents were detected in all cases
(range: 5–8% of non-sclerosed glomeruli) (Figure 1C) as well
as occasional older ﬁbrocellular or ﬁbrous crescents (range:
10–16% of non-sclerosed glomeruli) (Figure 1D). The inter-
stitium revealed moderate atrophy accompanied by focal
mild mononuclear inﬂammation largely conﬁned to the foci
of atrophy. Prominent arterial and arteriolar sclerosis was
detected in all biopsies.
Immunoﬂuorescence microscopy evaluation was always
negative for granular immune-type deposits (Table 2). In
contrast, all samples were characterized by the presence of
intense linear IgG staining of the GBM (IgG: Figure 2Aversus
albumin: Figure 2B). Less intense linear GBM staining for
kappa and lambda light chains was present in two of the
three samples while complement was negative in all biop-
sies. IgG subtyping revealed different results in all three pa-
tients; IgG1 was predominant in patient 1, IgG2 in patient 2
and IgG4 was the most prominent subtype in patient 3.
In addition to mesangial expansion (Figure 2C), ultrastruc-
tural evaluation revealed widespread signs of signiﬁcant
endothelial cell injury with expansion of the subendothelial
space by ﬂuffy electron-lucent material and signs of glom-
erular capillary wall remodeling (Figure 2D ) .S o m ed e g r e eo f
visceral epithelial cell foot process effacement was appre-
ciated in all samples (Figure 2Ca n dD ) .
In all three biopsies, the diagnoses of immune complex
GN, amyloidosis, monoclonal immunoglobulin deposition
disease, ﬁbrillary GN and immunotactoid glomerulopathy
could be excluded based on the negative immunoﬂuores-
cence and electron microscopy ﬁndings.
Treatment and follow-up
Patient 1 was treated with cyclophosphamide and prednis-
one but without plasmapheresis and showed only modest
improvement in serum creatinine [from 283 to 239 µmol/L
(3.2–2.7 mg/dL)]. Approximately 1 year post-biopsy, the
patient developed steroid-induced diabetes mellitus. Fol-
lowing the kidney biopsy, the patient quit smoking fora few
months and resumed smoking later. About 18 months
after the biopsy, the patient resumed smoking ∼10 cigar-
ettes per day, had chronic kidney disease stage IV with a
serum creatinine of 230 µmol/L (2.6 mg/dL).
Patient 2 was treated with prednisone, cyclophospha-
mide and plasmapheresis. Anti-GBM antibodies became
undetectable by western blot and serum creatinine de-
creased from 398 to 265 µmol/L (4.5–3 mg/dL) 3 weeks
after the beginning of treatment. However, 1 month later,
the patient’s renal function deteriorated again with a
serum creatinine of 433 µmol/L (4.9 mg/dL) and he even-
tually became hemodialysis dependent.
Patient 3 was treated with SoluMedrol and was put on li-
sinopril. About 2 years after the biopsy, this patient had
functioning kidneys but with an elevated serum creatinine
of 194–212 µmol/L (2.2–2.4 mg/dL), 500 µg/24 h of pro-
teinuria and no hematuria.
Discussion
Although nodular glomerulosclerosis is a characteristic
ﬁnding in patients with diabetic nephropathy [10], it is not
entirely speciﬁc for that entity. A similar pattern of injury
can be observed in other conditions, such as immune
complex-mediated GN (e.g. long-standing membranopro-
liferative GN), amyloidosis, monoclonal immunoglobulin
deposition disease, and ﬁbrillary and immunotactoid
glomerulopathy, which can be ruled out by careful im-
munoﬂuorescence and electron microscopy evaluation
[5]. In 1999, the term ING was applied to describe nodular
glomerulosclerosis occurring in the absence of all the
Table 2. Pathologic ﬁndings
Patient 1 Patient 2 Patient 3
Light microscopy
# Glomeruli 21 42 22
Global sclerosis (#, %) 1 (5%) 16 (38%) 9 (40%)
Segmental sclerosis (#, %) 0 (0%) 0 (0%) 0 (0%)
Glomerularcapillaries’ double contours Occasional Occasional Several
Endocapillary proliferation No No No
Cellular crescents (%)
a 1 (5%) 2 (8%) 1 (8%)
Fibrocellular and/or ﬁbrous crescents (%)
a 2 (10%) 3 (12%) 2 (16%)
Mesangial matrix expansion Diffuse Diffuse Diffuse
Mesangial cellularity Mild No Mild
Mesangial nodules Yes Yes Yes
Mesangiolysis Yes Yes Yes
Interstitial inﬂammation Mild and focal
b Mild and focal
b Mild and focal
b
Interstitial ﬁbrosis/tubularatrophy Moderate Moderate Moderate
Arterial sclerosis Moderate to severe Severe Moderate to severe
Arteriolar sclerosis Moderate to severe Severe Moderate to severe
Immunoﬂuorescence ﬁndings
Glomerular granular immune-type deposits No No No
Glomerular linear deposits IgG (4+), kappa
(4+), lambda (4+)
IgG (4+) IgG (3+), kappa (3+), lambda (3+)
IgG subtypes IgG2: 4+ IgG1 (4+), IgG4 (3+), IgG2 (2+) IgG4 (3+), IgG2 (2+), IgG1 (2+), IgG3 (1+)
Electron microscopy ﬁndings
Electron-dense deposits No No No




Cellular interposition and double contours Yes Yes Yes
GBM, glomerular basement membrane; TBM, tubular basement membrane.
aPercentage of non-globallysclerosed glomeruli.
bThe inﬂammation is largely conﬁned to the foci of atrophy.
Smoking and glomerular damage 363aforementioned conditions [11]. A relatively large study by
Markowitz et al. [3] revealed that ING is encountered in
∼0.5% of total renal biopsies and that the vast majority of
patients with ING had a signiﬁcant history of cigarette
smoking (mean cumulative intake of 53 packs/year) and
hypertension. These ﬁndings were soon conﬁrmed by
others [4]. In contrast to cigarette smoking, the causative
relationship between hypertension and ING is less
deﬁned; (i) not infrequently, ING can be encountered in
the absence of well-established hypertension [6] and
(ii) hypertension could arguably be considered the result
rather than the cause of renal endothelial cell injury [12].
In fact, smoking is known to induce direct oxidant injury
to the endothelium and elevation of blood pressure [13, 14],
which decreases again following smoking cessation [15].
Furthermore, ultrastructural signs of endothelial cell injury
were appreciated in the majority of ING samples from
chronic smokers who lacked a historyof hypertension [6]. In
the current study, all our patients developed a new onset of
hypertension up to 3 months before biopsies and showed
ultrastructural changes of widespread endothelial cell
injury and signiﬁcant glomerular capillary wall remodeling.
These ﬁndings could argue that the hypertension observed
in our patients appears to be the result of endothelial
cell injury probably triggered or aggravated by cigarette
smoking.
Anti-GBM disease is characterized by vascular injury
mediated by autoimmune anti-GBM antibodies which
could be initiated following a pathologic conformational
change in the GBM structures [16]. Such antibodies are
classically targeted against the α3 chain of type IV colla-
gen [17, 18]. Anti-GBM-GN is the most aggressive form of
GN [19] which often presents as a diffuse crescentic GN
[20]. The diagnosis of anti-GBM GN typically requires the
demonstration of serum anti-GBM antibodies together
with the typical histologic manifestation of anti-GBM-GN
including intense linear IgG staining along the GBM
20.
Detection of serum anti-GBM antibodies can be performed
by ELISA or western blot techniques. The latter is more
sensitive and speciﬁc and is particularly useful in patients
with low antibody titers [21]. Importantly, some studies
have shown that up to 13 and 3% of patients with anti-
GBM-GN had undetectable antibodies by ELISA [22]o rb y
both ELISA and western blot [20, 23], respectively. This
could sometimes be attributed to the sensitivity of the
currently used assays; using a highly sensitive IAsys bio-
sensor assay, Salama et al. [23] conﬁrmed the presence
of anti-α3 chain of type IV collagen antibodies in both pa-
tients with crescentic GN and intense linear IgG staining
along the GBM who had undetectable antibodies by both
ELISA and western blot methods (100%). The absence of
detectable antibodies could sometimes be ascribed to the
fact that some cases might develop antibodies to other
GBM antigens [24] possibly triggered by GBM injuryand ex-
posure of cryptic antigens; anti-GBM antibodies targeted
against agrin were observed in renal allograft recipients
Fig. 1. (A) Glomerulus with nodular mesangial expansion and mesangiolysis (arrowheads); two capillary loops on the left show microaneurysmal
dilatation and endothelial cell swelling (periodic acid-Schiff stain, original magniﬁcation ×600). (B) Prominent mesangial expansion due to segmental
mesangiolysis is noted on the left side of the tuft; the remaining portion of the tuft shows mild mesangial expansion and no signiﬁcant hypercellularity
(periodic acid-Schiff stain, original magniﬁcation ×600). (C) Glomerulus with a small cellular crescent and mesangial expansion (periodic acid-Schiff stain,
original magniﬁcation ×400). (D) Glomerulus with a healing extracapillary inﬂammatory lesion (ﬁbrocellular crescent) and nodular mesangial expansion
(periodic acid-Schiff stain, original magniﬁcation ×400).
364 I. Batal et al.with chronic transplant glomerulopathy who had previous
episodes of rejection [25]. These aforementioned data
have prompted some authorities to consider histologic
ﬁndings to be diagnostic for anti-GBM disease if compat-
ible with clinical features despite negative antibody detec-
tion in the serum [23].
A causative relationship between cigarette smoking and
anti-GBM disease has been suggested based on the high
prevalence of cigarette smoking in patients with Goodpas-
ture syndrome and pulmonary manifestations [7–9]. Such
association was less obvious in patients with isolated
anti-GBM-GN [26–28]. It has been proposed that smoking
can increase endothelial permeability and enable pre-
existing antibodies to bind to their basement membrane
antigens [9] or can induce direct basement membrane
injury [9] and inhibit the enzymes which catalyze formation
of sulﬁlimine bonds [16] to expose cryptic antigens and
promote antibody formation. All our biopsies were
associated with ultrastructural signs of endothelial cell
injury and glomerular capillary remodeling which could have
contributed to antigen exposure and/or antibody binding.
Despite the association of smoking with each of ING an
anti-GBM disease, no reports of anti-GBM-GN in the
presence of ING on a kidney biopsy have been previously
published. Interestingly, however, anti-GBM antibodies
were detectable in 9% of patients with IGN in the study
by Markowitz et al. [3] but without any description of
crescents. In the current study, we describe the ﬁrst case
series of patients with non-diabetic nodular glomerulo-
sclerosis and anti-GBM-like GN. All our patients were
heavy smokers. Although all these cases were encoun-
tered in the last 2 years, a search for a combination of
nodular glomerulosclerosis and features of anti-GBM GN
during the past 7 years in our archives failed to uncover
additional cases, suggesting that this pattern of glomeru-
lar injury is rarelyencountered.
Kidney biopsy from all three patients revealed ultra-
structural signs of endothelial injury, diffuse mesangial
matrix expansion, nodular pattern of glomerulosclerosis,
intense linear IgG staining along the GBM in the presence
of occasional cellular, ﬁbrocellular and ﬁbrous crescents.
In our study, the superimposed anti-GBM-like GN was
atypical for the following reasons: (i) anti-GBM antibodies
in serum were only detectable in one of three (33%) pa-
tients. We cannot ascertain whether the lackof detectable
anti-GBM antibodies in the other two patients was due to
low titer and the lack of sensitivity (western blot testing
was not performed in patient 1), or to the presence of
antibodies targeted to different GBM antigens. (ii)
In contrast to classic anti-GBM-GN where IgG1 is the pre-
dominant subtype [8], IgG2 and IgG4 subtypes predominate
in 2 of 3 of our patients. IgG2 ﬁxes complement poorly
Fig. 2. (A) Immunoﬂuorescence evaluation revealed an intense linear staining for immunoglobulin G (IgG antibody, immunoﬂuorescence microscopy,
original magniﬁcation ×200). (B) Albumin staining of the same glomerulus in picture (A) revealed no signiﬁcant linear reactivity along the glomerular or
tubular basement membranes (immunoﬂuorescence microscopy, original magniﬁcation ×400). (C) Electron microscopy examination revealed mesangial
expansion by matrix and mild effacement of podocyte foot processes, in the absence of electron-dense deposits (electron microscopy, original
magniﬁcation ×3000). (D) Ultrastructural detail of a peripheral capillary wall with subendothelial expansion by electron-lucent ﬂuffy material; discrete
wisps of new basement membrane material are formed under the displaced endothelium (electron microscopy, original magniﬁcation ×8000).
Smoking and glomerular damage 365while IgG4 is not capable of ﬁxing the complement [29, 30].
In anti-GBM-GN, these subtypes of antibodies are rarely
encountered and often associated with a less aggressive
form of the disease [31]. (iii) In our series, occasional non-
circumferential crescents in different stages of development
were always observed; this is different from typical anti-
GBM-GN where the biopsy usually reveals synchronized
and circumferential crescents involving the majority of
glomeruli [22].
Aggressive treatment with plasmapheresis was per-
formed only in one patient who lost his kidney function,
while the other two patients who were treated less ag-
gressively have been dialysis-free, at least till the time of
writing. Of note, the patient who lost the kidney function
had prominent endothelial cell injury and signiﬁcant
chronic damage on the kidney biopsy, and he was the only
one with detectable anti-GBM antibodies in serum by
western blot, with a predominance of IgG1 subtype on im-
munoﬂuorescence microscopy.
In conclusion, we report here the ﬁrst case series of
a rare but distinct pattern of glomerular injury observed
in heavy smokers without clinical history of diabetes,
with kidney biopsy ﬁndings of nodular glomerulosclerosis,
endothelial cell injury, linear anti-GBM effect on immuno-
ﬂuorescence studies, and occasional crescent formation
in some glomeruli. Our ﬁndings highlight the important
association of smoking with endothelial injury, glomerular
mesangial expansion and crescent formation. Our study
also highlights the need for a prudent search for cellular
crescents when strong intense linear IgG is observed
along the GBM. Finally, the fact that this pattern of dual
injury is not observed in all patients who smoke heavily
suggests that a possible second hit or a genetic predispos-
ition may be necessary to develop such complication.
Conﬂict of interest statement. None declared.
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